In the face of a debilitating disease, Glenn Rowan's story is a stark reminder of the harsh realities of the aged care system in Australia. His battle with motor neurone disease (MND) has left him with a difficult choice: to either bleed his savings to fund 24/7 care or to consider premature euthanasia. This is a dilemma that many older Australians with MND are facing, as the aged care system falls short of providing adequate support.
The aged care system, designed for general ageing-related needs, is ill-equipped to handle the severe disabilities associated with MND. While the National Disability Insurance Scheme (NDIS) offers more comprehensive funding, those diagnosed after the age of 65 are ineligible. This leaves a significant funding gap, with the Support at Home program falling far short of the actual costs.
The case of Glenn Rowan highlights the urgency of this issue. With a weekly disability support cost of $7,000 out of his own pocket, he is struggling to manage even the most basic tasks. The aged care funding, although adequate for day-to-day needs, becomes insufficient when paralysis sets in, requiring 24/7 care that costs at least $400,000.
The recent announcement of fast-tracked funding for MND patients over 65 is a step in the right direction. However, it does not address the underlying issue of inadequate funding. MND Australia's chief executive, Clare Sullivan, rightly points out that families are being financially crippled, and the automated assessment tool often fails to categorize MND patients at the highest funding level.
The lack of price caps regulating the increased cost of at-home care services is another concern. As a result, funding support for MND patients is buying them less, exacerbating the financial burden. Independent Senator David Pocock emphasizes the need for flexibility in the assessment tool to consider the unique needs of MND patients.
The rapid physical deterioration of MND sets it apart from other neurological diseases typically associated with ageing. The aged care residential sector, designed for Alzheimer's disease, is ill-equipped to handle severe physical disabilities. This highlights the need for a more tailored approach to funding and support for MND patients.
In my opinion, the Australian government must take urgent action to address the funding gap for older Australians with MND. The current system is failing those in need, and the consequences are devastating. It is time to reevaluate the aged care system and ensure that it provides the necessary support for individuals like Glenn Rowan, who are facing the harsh realities of living with a debilitating disease.
